SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-21-000031
Filing Date
2021-05-07
Accepted
2021-05-07 16:26:35
Documents
91
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20210331x10q.htm   iXBRL 10-Q 2200591
2 EX-31.1 amph-20210331ex311bc3af2.htm EX-31.1 18826
3 EX-31.2 amph-20210331ex312400750.htm EX-31.2 18481
4 EX-32.1 amph-20210331ex32127a626.htm EX-32.1 9565
5 EX-32.2 amph-20210331ex32219a512.htm EX-32.2 9566
  Complete submission text file 0001297184-21-000031.txt   9580280

Data Files

Seq Description Document Type Size
6 EX-101.SCH amph-20210331.xsd EX-101.SCH 63431
7 EX-101.CAL amph-20210331_cal.xml EX-101.CAL 63690
8 EX-101.DEF amph-20210331_def.xml EX-101.DEF 219808
9 EX-101.LAB amph-20210331_lab.xml EX-101.LAB 483495
10 EX-101.PRE amph-20210331_pre.xml EX-101.PRE 429537
11 EXTRACTED XBRL INSTANCE DOCUMENT amph-20210331x10q_htm.xml XML 2015676
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 21903152
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences